BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 28455449)

  • 21. PIASy inhibits virus-induced and interferon-stimulated transcription through distinct mechanisms.
    Kubota T; Matsuoka M; Xu S; Otsuki N; Takeda M; Kato A; Ozato K
    J Biol Chem; 2011 Mar; 286(10):8165-8175. PubMed ID: 21199872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
    Mabb AM; Wuerzberger-Davis SM; Miyamoto S
    Nat Cell Biol; 2006 Sep; 8(9):986-93. PubMed ID: 16906147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yeast PIAS-type Ull1/Siz1 is composed of SUMO ligase and regulatory domains.
    Takahashi Y; Kikuchi Y
    J Biol Chem; 2005 Oct; 280(43):35822-8. PubMed ID: 16109721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
    Ihara M; Yamamoto H; Kikuchi A
    Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of yeast PIAS-type SUMO ligases in vivo and in vitro.
    Takahashi Y; Toh-E A; Kikuchi Y
    J Biochem; 2003 Apr; 133(4):415-22. PubMed ID: 12761287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
    Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
    J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SUMO2/3 modification of activating transcription factor 5 (ATF5) controls its dynamic translocation at the centrosome.
    Yuan Y; Gaither K; Kim E; Liu E; Hu M; Lengel K; Qian D; Xu Y; Wang B; Knipprath H; Liu DX
    J Biol Chem; 2018 Feb; 293(8):2939-2948. PubMed ID: 29326161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PIASγ controls stability and facilitates SUMO-2 conjugation to CoREST family of transcriptional co-repressors.
    Sáez JE; Arredondo C; Rivera C; Andrés ME
    Biochem J; 2018 Apr; 475(8):1441-1454. PubMed ID: 29555846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization.
    Fuhs SR; Insel PA
    J Biol Chem; 2011 Apr; 286(17):14830-41. PubMed ID: 21362625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity.
    Merrill JC; Melhuish TA; Kagey MH; Yang SH; Sharrocks AD; Wotton D
    PLoS One; 2010 Jan; 5(1):e8794. PubMed ID: 20098713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
    Dütting E; Schröder-Kress N; Sticht H; Enz R
    Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.
    Tripathi V; Chatterjee KS; Das R
    J Biol Chem; 2019 Oct; 294(40):14546-14561. PubMed ID: 31371453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy.
    Chun TH; Itoh H; Subramanian L; Iñiguez-Lluhí JA; Nakao K
    Circ Res; 2003 Jun; 92(11):1201-8. PubMed ID: 12750312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.
    Martin N; Schwamborn K; Urlaub H; Gan B; Guan JL; Dejean A
    Mol Cell Biol; 2008 Apr; 28(8):2771-81. PubMed ID: 18285457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms in SUMO conjugation.
    Varejão N; Lascorz J; Li Y; Reverter D
    Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Basis for Phosphorylation-dependent SUMO Recognition by the DNA Repair Protein RAP80.
    Anamika ; Spyracopoulos L
    J Biol Chem; 2016 Feb; 291(9):4417-28. PubMed ID: 26719330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes.
    Azuma Y; Arnaoutov A; Anan T; Dasso M
    EMBO J; 2005 Jun; 24(12):2172-82. PubMed ID: 15933717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells.
    Huang CH; Yang TT; Lin KI
    J Biomed Sci; 2024 Jan; 31(1):16. PubMed ID: 38280996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.
    Higginbotham JM; O'Shea CC
    J Virol; 2015 Oct; 89(20):10260-72. PubMed ID: 26223632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.